Analysis of prognostic factors and construction of prognostic models for invasive lobular carcinoma of the breast
View abstract on PubMed
Summary
This summary is machine-generated.Invasive lobular carcinoma (ILC) patients show better survival than invasive ductal carcinoma (IDC) patients. Prognostic factors for ILC include TNM stage, age, ER/PR status, and HER2 status, aiding survival prediction.
Area Of Science
- Oncology
- Cancer Research
- Epidemiology
Background
- Invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) are the most common types of breast cancer.
- There is ongoing debate regarding differences in overall survival (OS) between ILC and IDC.
Purpose Of The Study
- To compare the overall survival (OS) between ILC and IDC.
- To identify prognostic factors for ILC patients.
- To develop a nomogram for predicting OS in ILC patients.
Main Methods
- Retrospective cohort analysis using the SEER Cancer Database (2000-2019).
- Propensity score matching (PSM) to balance baseline characteristics.
- Multivariate Cox regression to identify prognostic factors and construct a nomogram.
Main Results
- After PSM, ILC patients demonstrated a better prognosis than IDC patients.
- Independent prognostic factors for ILC OS included TNM stage, age >70, radiotherapy, surgery, ER, PR, and HR-/HER2+ subtype.
- Surgery and radiotherapy were associated with reduced mortality risk; chemotherapy did not show a significant benefit.
Conclusions
- ILC patients generally have a better prognosis than IDC patients.
- A predictive nomogram incorporating identified prognostic factors can aid in OS estimation for ILC.
- The findings support clinical decision-making and patient counseling regarding ILC prognosis.

